Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Current guidelines for Kawasaki disease (KD) recommend intravenous immunoglobulin infusion and echocardiography. However, no previous studies have evaluated the relationship between the treating hospital's concordance with guidelines and the prevention of coronary artery aneurysm in patients with KD.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Clin Pediatr (Phila)

Title: Clinical pediatrics

Publisher: SAGE Publications

ISSN (Electronic): 1938-2707

ISSN (Print): 0009-9228

Publication date (Electronic): Oct 2015

Volume: 54

Issue: 11

Affiliations

[1 ] Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan michihata-tky@umin.org.

[2 ] Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.

[3 ] Department of Health Policy and Informatics, Tokyo Medical and Dental University, Graduate School of Medicine, Tokyo, Japan.

Article

Publisher Item ID: 0009922814566932

DOI: 10.1177/0009922814566932

PubMed ID: 25573948

SO-VID: 053d9c82-edc4-4ad1-a399-c8986461aa82

History

Keywords: Kawasaki disease,coronary artery aneurysm,guideline concordance,epidemiology

Data availability:

Keywords: Kawasaki disease, coronary artery aneurysm, guideline concordance, epidemiology

Comments

Comment on this article

scite_